Cargando…

Price Increases and New Drugs Drive Increased Expenditures for Multiple Sclerosis

Detalles Bibliográficos
Autores principales:	Schafer, Jeremy A., Gunderson, Brent W., Gleason, Patrick P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2010
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438252/ https://www.ncbi.nlm.nih.gov/pubmed/21067257 http://dx.doi.org/10.18553/jmcp.2010.16.9.713

Ejemplares similares

Utilization, Cost Trends, and Member Cost - Share for Self-Injectable Multiple Sclerosis Drugs-Pharmacy and Medical Benefit Spending From 2004 Through 2007
por: Kunze, April M., et al.
Publicado: (2007)

Generic Drug Discount Programs: Are Prescriptions Being Submitted for Pharmacy Benefit Adjudication?
por: Tungol, Alexandra, et al.
Publicado: (2012)

For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs
por: Shin, Gyeongseon, et al.
Publicado: (2022)

Immunotherapy for Head and Neck Cancer in the Era of Exponentially Increasing Health Care Expenditure
por: Santana‐Davila, Rafael, et al.
Publicado: (2017)

The Rising Cost of Insulin for Pump Users: How Policy Drives Prices
por: Brown-Georgi, Julia, et al.
Publicado: (2020)

The 20-year impact of tobacco price and tobacco control expenditure increases in Minnesota, 1998-2017
por: Maciosek, Michael V., et al.
Publicado: (2020)

Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy Medications
por: Gleason, Patrick, et al.
Publicado: (2009)

Does drug price-regulation affect healthcare expenditures?
por: Ben-Aharon, Omer, et al.
Publicado: (2016)

Kappa opioid receptor activation increases thermogenic energy expenditure which drives increased feeding
por: Cone, Aaron L., et al.
Publicado: (2023)

Serum markers of multiple sclerosis - a new approach
por: Torkildsen, Øivind
Publicado: (2021)

Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022
por: Alrasheed, Marwan, et al.
Publicado: (2023)

Affordability and Price Increases of New Cancer Drugs in Clinical Guidelines, 2007–2016
por: Hwang, Thomas J, et al.
Publicado: (2018)

What Is the Price Benchmark to Replace Average Wholesale Price (AWP)?
por: Curtiss, Frederic R.
Publicado: (2010)

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier
por: Yeandle, David, et al.
Publicado: (2018)

Fungal microbiome and multiple sclerosis: The not-so-new kid on the block
por: Mangalam, Ashutosh K.
Publicado: (2021)

An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
por: Alroughani, Raed, et al.
Publicado: (2019)

Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?
por: Rivera, Victor M.
Publicado: (2019)

Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies
por: Iyer, Priyanka, et al.
Publicado: (2022)

Effects of drug price reduction and prescribing restrictions on expenditures and utilisation of antihypertensive drugs in Korea
por: Yoo, Ki-Bong, et al.
Publicado: (2015)

New generation indirect calorimeters for measuring energy expenditure in the critically ill: a rampant or reticent revolution?
por: De Waele, Elisabeth, et al.
Publicado: (2016)

Antifungal drug price increases in the United States, 2000–2019
por: Thomas, Christine M., et al.
Publicado: (2022)

The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients
por: Kloc, Malgorzata, et al.
Publicado: (2020)

Multiple Sclerosis and Catastrophic Health Expenditure in Iran
por: Juyani, Yaser, et al.
Publicado: (2016)

Own-price, cross-price, and expenditure elasticities on sugar-sweetened beverages in Guatemala
por: Chacon, Violeta, et al.
Publicado: (2018)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

Vaccine pricing strategies in China
por: Zhang, Haonan, et al.
Publicado: (2023)

Drink Driving as the Commonest Drug Driving—A Perspective from Europe
por: Allsop, Richard
Publicado: (2020)

Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
por: Steinberg, Judith, et al.
Publicado: (2019)

Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Participatory Medicine
por: Kantor, Daniel, et al.
Publicado: (2017)

Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Patient Education
por: Kantor, Daniel, et al.
Publicado: (2017)

New technology expected to increase sharpness, reduce prices of scalpels
Publicado: (2002)

Rising gasoline prices increase new motorcycle sales and fatalities
por: Zhu, He, et al.
Publicado: (2015)

Increases in Anti-infective Drug Prices, Subsequent Prescribing, and Outpatient Costs
por: Lee, Junsoo, et al.
Publicado: (2021)

The Economics of Viagra Revisited: The Price Is Right
por: Agochukwu-Mmonu, Nnenaya, et al.
Publicado: (2021)

The influences of Taiwan's generic grouping price policy on drug prices and expenditures: Evidence from analysing the consumption of the three most-used classes of cardiovascular drugs
por: Chen, Chi-Liang, et al.
Publicado: (2008)

Following the path: Increasing trends of HIV-1 drug resistance in China
por: Gupta, Soham, et al.
Publicado: (2020)

Get Rich Quick With Old Generic Drugs! The Pyrimethamine Pricing Scandal
por: Gallant, Joel
Publicado: (2015)

Impact of khat price increases on consumption behavior – price elasticity analysis
por: El-Setouhy, Maged, et al.
Publicado: (2019)

Increased respiratory drive relates to severity of dyspnea in systemic sclerosis
por: Ninaber, Maarten K, et al.
Publicado: (2014)

Consider expenditure controls’ impacts on equity
por: Frick, Kevin D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6e81h7u20bad69utveioncmtff